Firdapse Approved for Rare Autoimmune Disorder

THURSDAY, Nov. 29, 2018 — Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).
It’s the first agency-sanctioned treatment for the autoimmune disease…
Source: Firdapse Approved for Rare Autoimmune Disorder